Pulsenmore(PLSM.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Pulsenmore
PLSM.US
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.
1.353 T
PLSM.USMarket value -Rank by Market Cap -/-

Financial Score

28/01/2026 Update
C
Health Care EquipmentIndustry
Industry Ranking94/176
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-45.93%E
    • Profit Margin-472.58%E
    • Gross Margin36.43%C
  • Growth ScoreB
    • Revenue YoY18.14%B
    • Net Profit YoY13.01%C
    • Total Assets YoY-17.11%E
    • Net Assets YoY-29.10%E
  • Cash ScoreC
    • Cash Flow Margin-21.16%D
    • OCF YoY18.14%B
  • Operating ScoreE
    • Turnover0.07E
  • Debt ScoreB
    • Gearing Ratio38.08%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

    In Wednesday's pre-market session, several health care stocks experienced notable movements. ENvue Medical (NASDAQ:FEED) surged 19.0% to $1.25, while Pulsenmore (NASDAQ:PLSM) rose 14.33% to $7.1. Shuttle Pharmaceuticals (NASDAQ:SHPH) increased by 13.3% to $2.3. Conversely, Altimmune (NASDAQ:ALT) saw a decline of 13.4% to $5.35, and Vyome Holdings (NASDAQ:HIND) fell 12.89% to $2.84. Other notable gainers included Hyperliquid Strategies (NASDAQ:PURR) and Korro Bio (NASDAQ:KRRO), while USBC (AMEX:USBC) and Genenta Science (NASDAQ:GNTA) were among the losers.

    benzinga_article·
    US
    PLSM
    -0.16%
    US
    SHPH
    +6.65%
    US
    FEED
    +141.90%
    benzinga_article·
    US
    PLSM
    -0.16%
    US
    SHPH
    +6.65%
    US
    FEED
    +141.90%

    Pulsenmore and Clalit Health collaborate for at-home follicular monitoring service for IVF, valued at $4.5 million over 5 years.

    A commercial deal worth around $4.5 million is on the horizon for Pulsenmore Ltd. Following an 18-month pilot, this agreement is projected to span five years. The service is set to be rolled out through Beilinson NEXT, Beilinson's virtual hospital located in Ramat Gan, Israel. Pulsenmore Ltd., a global company listed on NASDAQ as PLSM and TASE as PLSM, announced the details on Jan. 26, 2026.

    Unusual Whales·
    US
    PLSM
    -0.16%
    Unusual Whales·
    US
    PLSM
    -0.16%

    Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation | PLSM Stock News

    Pulsenmore Ltd. has entered a strategic commercial agreement with Clalit Health Services to launch an at-home follicular monitoring service for IVF and fertility preservation, valued at approximately $4.5 million over five years. The service will be operated through Beilinson NEXT, allowing eligible patients to perform scans from home with real-time guidance. This initiative aims to enhance patient convenience while maintaining clinical oversight, reducing the need for in-clinic visits. Both companies are optimistic about the potential impact of this service on fertility care delivery.

    StockTitan·
    US
    PLSM
    -0.16%
    StockTitan·
    US
    PLSM
    -0.16%
    © 2026 Longbridge｜Disclaimer